Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Diurnal Group plc

Headquarters: Cardiff, United Kingdom
Website: N/A
Year Founded: 2004
Status: Acquired

BioCentury | Nov 16, 2022
Management Tracks

Bungay becomes CEO at Imophoron, Garzoni transitions to CSO

Plus: Tracy named CTO at Code, and updates from ConcertAI, Lucy, Trevi and more
BioCentury | Aug 30, 2022
Product Development

Aug. 30 Quick Takes: Lumakras meets in lung cancer Phase III

Plus vopratelimab miss weighs on Jounce and updates from MedGenome, Sangamo and more
BioCentury | Nov 16, 2021
Management Tracks

End of an era at Biogen as R&D head Sandrock readies to retire 

Plus: Levin-Allerhand joins Flagship, and updates from Alchemab, Agios, Actym, Gilgamesh and more
BioCentury | Jun 20, 2018
Company News

Management tracks: Sanofi, NantKwest

BioCentury | Feb 16, 2018
Clinical News

EC approves Diurnal's Alkindi

BioCentury | Feb 13, 2018
Company News

EC approves Diurnal's Alkindi

BioCentury | Apr 20, 2017
Company News

Diurnal, Clinigen sales and marketing update

Items per page:
1 - 8 of 8